PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 13(Suppl_2): 380-382 1993
© 1993 International Society for Peritoneal Dialysis
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fabris, A
Right arrow Articles by Bolzonella, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fabris, A
Right arrow Articles by Bolzonella, R
Peritoneal Dialysis International, Vol 13, Issue Suppl_2, S380-S382
Copyright © 1993 by International Society for Peritoneal Dialysis


Articles

Pharmacokinetics of antifungal agents

A Fabris, MV Pellanda, C Gardin, A Contestabile, and R Bolzonella

Nephrology and Dialysis Service, Ospedale Di Bassano Del Grappa, Italy.

The authors have evaluated the pharmacokinetics of four antifungal agents used in the therapy of fungal peritonitis. Amphotericin B (Amph B) poorly diffuses from blood into peritoneal fluid, which intraperitoneal administration induces severe abdominal pain. 5-Fluorocytosine (5FC) easily crosses peritoneum, but resistance may appear when the drug is used alone. Ketoconazole (K) poorly penetrates into peritoneal fluid, while Fluconazole (F), used per os or intraperitoneally, shows a good antifungal activity both in serum and in the peritoneal fluid. In conclusion, from a pharmacokinetic point of view, all the antifungal agents examined, perhaps with the exception of F, do not offer, when used alone, sufficient guarantees in curing peritonitis. Therefore, for treating fungal infections in CAPD, drug combinations such as AmphB + 5FC, K + 5FC or 5FC+F have to be used.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1993 by Multimed Inc.